Menu
Subscribe to our Email Alerts
Home
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Pipeline
Cancer Program
Fibrosis Program
Clinical Trial
Investor Information
Welcome
Investor Fact Sheet
Investor Presentations
Media
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements and Reports
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
Contact Us
Contact Us
Email Alerts
Announcements and Reports
Home
>
Announcements and Reports
>
ASX Announcements
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
ASX Announcements
Filter by Year:
2023
2022
2021
2020
2019
2018
17-Aug-2022
Annual General Meeting - ESOP and New Constitution
17-Aug-2022
Employee Security Ownership Plan
4-Aug-2022
Change of Director's Interest Notice - Dr. Warwick Tong
2-Aug-2022
First Patient Recruited to ACCENT Trial in Pancreatic Cancer
28-Jul-2022
Quarterly Activities and Cashflow Reports - June 2022 Qtr
25-Jul-2022
Presentation at Major Pancreatic Cancer Conference
22-Jul-2022
Notice of Annual General Meeting/Proxy - YE 31 March 2022
7-Jul-2022
Change of Director's Interest Notice - Dr. Chistopher Burns
7-Jul-2022
Change of Director's Interest Notice - Dr. Robert Peach
7-Jul-2022
Change of Director's Interest Notice - Dr. John Lambert
Previous
1
2
3
4
5
6
Next
